Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

Aventis Pharma S.A. v. Accord Healthcare Inc. USA, No. 11-1442 (Fed. Cir. Aug. 10, 2012)

Affirmed
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 11-1442
Decided
August 10, 2012
Judge
See opinion
Document
Nonprecedential Opinion
Length
3 pages

Note: This order is nonprecedential. Gnited States Court of Appeals

for the federal Circuit

AVENTIS PHARMA S.A. anp SANOFI-AVENTIS U.S.

LLC,

Piaintiffs-Appellants,

Vv.

ACCORD HEALTHCARE INC. USA,

Defendant-Appellee.

2011-1442

Appeal from the United States District Court for the District of Delaware in case no. 11-CV-0018, Chief Judge Gregory M. Sleet.

ORDER

Before Prost, MAYER, and REYNA, Circuit Judges.

Figure on page 1 of the opinion

ORDER

The court construes Aventis Pharma S.A. and Sanofi-Aventis U.S., LLC (“Aventis”)’s response to this court’s March 17, 2011 order as an unopposed motion to lift the stay and summarily afÏrm the judgment of the United States District Court for the District of Delaware.

Figure on page 2 of the opinion

2AVENTIS PHARMA v. ACCORD HEALTHCARE 2

This appeal arises out of a complaint filed by Aventis in the district court alleging infringement of U.S. Patent Nos. 5,714,512B1 and 5,750,561. In a related case, Aventis Pharma S.A. v. Hospira, Inc., 07-CV-0721 (D. Del. 2010) (Hospira), the district court found that the same patent claims asserted in this case were invalid and unenforceable due to inequitable conduct. In light of Hospira, the district court entered final judgment in this case against Aventis, and Aventis appealed to this court. This court stayed proceedings pending final disposition of Hospira.

On April 9, 2012, this court afÏrmed the district court’s judgment in Hospira. See Aventis Pharma S.A. v. Hospira, Inc., 675 F.3d 1324 (Fed. Cir. 2012). In light of this court’s decision in Hospira, Aventis concedes that the district court’s judgment in this case should be consistent with Hospira.

Accordingly, It Is ORDERED THAT: (1) The motion is granted. The stay is lifted and the judgment of the district court is afÏrmed.

(2) Each side shall bear its own costs. (3) All pending motions are moot.

For THE COURT Aus 10 2012 ‘si J

an Horbaly Date Jan Horbaly

Clerk

uag ear”

AUG 16 2012

JAN HORBALY

CLERK

Figure on page 3 of the opinion

33 AVENTIS PHARMA V. ACCORD HEALTHCARE

ce: George F. Pappas, Esq.

Michael R. Dzwonczyk, Esq.

825

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Aventis Pharma S.A. v. Accord Healthcare Inc. USA, No. 11-1442 (Fed. Cir. Aug. 10, 2012).

Record ID
CAFC-11-1442-20120810
Permalink
https://patentcasewatch.com/opinions/CAFC-11-1442-20120810

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.